ALB:NYE-Albemarle Corporation (USD)

COMMON STOCK | Specialty Chemicals | NYE

Last Closing Price

USD 84.84

Change

+0.32 (+0.38)%

Market Cap

USD 8.99B

Volume

1.43M

Average Target Price

USD 71.75 (-15.43%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company operates in three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment offers hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. The company serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1994 and is headquartered in Charlotte, North Carolina. Address: 4250 Congress Street, Charlotte, NC, United States, 28209

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-28 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN Linde plc

+4.30 (+1.85%)

USD122.28B 55.83 17.35
SHW The Sherwin-Williams Company

+9.61 (+1.38%)

USD63.50B 35.97 23.76
ECL Ecolab Inc

+2.24 (+1.14%)

USD55.94B 40.97 21.55
PPG PPG Industries, Inc

+1.49 (+1.24%)

USD28.38B 28.19 16.61
LYB LyondellBasell Industries N.V

+1.59 (+2.28%)

USD23.59B 11.57 8.70
IFF International Flavors & Fragra..

+2.43 (+2.04%)

USD12.72B 31.25 16.80
AVTR Avantor, Inc

+0.27 (+1.23%)

USD12.70B 21.08 17.97
AVTR-PA Avantor, Inc

-49.41 (-68.90%)

USD11.79B N/A N/A
RPM RPM International Inc

+1.37 (+1.69%)

USD10.54B 34.06 19.40
WLK Westlake Chemical Corporation

+2.03 (+3.35%)

USD7.73B 20.23 8.35

ETFs Containing ALB

Symbol Name Weight Mer Price(Change) Market Cap
EZM WisdomTree U.S. MidCap Ea.. 0.00 % 0.38 %

+0.86 (+2.57%)

USD0.55B
GNRX VanEck Vectors Generic Dr.. 0.00 % 0.55 %

N/A

USD3.35M
LIT Global X Lithium & Batter.. 0.00 % 0.75 %

+0.59 (+1.57%)

USD0.76B
QCLN First Trust NASDAQ Clean .. 0.00 % 0.60 %

+1.90 (+4.69%)

USD0.48B
BATT:LSE L&G Battery Value-Cha.. 0.00 % 0.49 %

+0.31 (+2.95%)

USD0.06B
IUSZ:LSE iShares IV Public Limited.. 0.00 % 0.20 %

+0.21 (+3.05%)

USD0.06B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.16% 92% A- 87% B+
Dividend Return 1.58% 58% F 50% F
Total Return 17.74% 92% A- 87% B+
Trailing 12 Months  
Capital Gain 22.04% 87% B+ 86% B
Dividend Return 2.19% 50% F 48% F
Total Return 24.23% 87% B+ 86% B
Trailing 5 Years  
Capital Gain 92.38% 78% C+ 86% B
Dividend Return 15.32% 55% F 49% F
Total Return 107.70% 78% C+ 86% B
Average Annual (5 Year Horizon)  
Capital Gain 10.65% N/A N/A 80% B-
Dividend Return 1.61% N/A N/A 46% F
Total Return 12.26% N/A N/A 79% C+
Risk Return Profile  
Volatility (Standard Deviation) 39.59% N/A N/A 12% F
Risk Adjusted Return 30.97% N/A N/A 48% F
Market Capitalization 8.99B 77% C+ 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.22 62% D- 38% F
Price/Book Ratio 2.20 55% F 33% F
Price / Cash Flow Ratio 12.50 41% F 28% F
EV/EBITDA 15.86 45% F 33% F
Management Effectiveness  
Return on Equity 12.35% 64% D 76% C
Return on Invested Capital 8.73% 54% F 67% D+
Return on Assets 4.53% 59% F 77% C+
Debt to Equity Ratio 71.31% 59% F 48% F
Technical Ratios  
Short Ratio 11.15 18% F 6% F
Short Percent 9.98% 16% F 38% F
Beta 1.41 54% F 29% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.